Search This Blog

Wednesday, February 19, 2020

Reata Pharmaceuticals EPS misses by $0.76, misses on revenue

Reata Pharmaceuticals (NASDAQ:RETA): Q4 Non-GAAP EPS of -$1.59; GAAP EPS of -$5.91 misses by $0.76.
Revenue of $2.67M (-68.4% Y/Y) misses by $5.3M.
Shares +0.21%.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)